Cytomyx Holdings becomes first biotech company to list on AIM this year, raising £2m

Cytomyx Holdings becomes first biotech company to list on AIM this year, raising £2m. Cytomyx advised by Memery Crystal (Andrew Titmas). Broker Hoodless Brennan & Partners advised by Wedlake Bell. Nominated adviser Corporate Synergy advised by Clyde & Co.